24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients.

van Leeuwen, DJ; Yee, Leland J; Langner, Rebecca G; (2002) 24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients. The American journal of gastroenterology, 97 (2). pp. 497-498. ISSN 0002-9270 DOI: https://doi.org/10.1111/j.1572-0241.2002.05512.x

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar